The U.S. Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing cosmetics for asbestos. The FDA noted that this move aims to protect consumers from potential harm posed by asbestos, a known carcinogen linked to serious illnesses such as lung and ovarian cancers.

Talc is a natural mineral widely used in cosmetics and personal care products for purposes such as moisture absorption, preventing clumping, providing opacity to cosmetics, and improving product texture. However, since talc and asbestos can coexist in the same rock types and may contaminate each other during mining, testing for asbestos in cosmetics is crucial.

The FDA has long been sampling and testing talc-containing cosmetics for asbestos and collaborating with federal partners to reduce consumer exposure to asbestos risks. After considering scientific evidence and complex policy issues related to testing and identifying talc and asbestos in talc-containing cosmetics, the FDA believes the proposed testing techniques are appropriate for detecting asbestos and will help ensure the safety of talc-containing cosmetics. FDA proposed requiring manufacturers to use methods such as polarized light microscopy (PLM) and transmission electron microscopy/energy dispersive X-ray spectroscopy/selective area electron diffraction (TEM/EDS/SAED) for asbestos testing.

The proposed rule mandates manufacturers to test representative samples from each batch of talc-containing cosmetics or representative samples from each batch of talc ingredients used in cosmetics.

Moreover, if manufacturers can establish and maintain the reliability of supplier analytical certificates through validation testing and determine the qualifications of suppliers, they may rely on the supplier’s analytical certificate for talc. If manufacturers fail to comply with the testing or record-keeping requirements in the rule, their talc-containing cosmetics will be considered adulterated  under Section 601(c) of the Federal Food, Drug, and Cosmetic Act.

Additionally, if the cosmetics contain asbestos, or if the talc used in cosmetics contains asbestos, the cosmetics will be deemed adulterated under Section 601(a) of the Federal Food, Drug, and Cosmetic Act. Similarly, if the talc used in cosmetics contains asbestos, that talc will also be considered adulterated under Section 601(a) of the Federal Food, Drug, and Cosmetic Act.

The implementation of the proposed rule will help protect consumers to some extent and reduce the chances of asbestos exposure, thereby lowering the risk of asbestos-related diseases.

Reference:

FDA: Talc Cosmetics Will Mandate Asbestos Testing

READ MORE
Exim rebrands as ExSyn: We celebrate our 30-year heritage with a new brand and website that bring alive our values and purpose
News · 27/03/2021

Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.

In focus: Peppermint Microencapsulated Powder
Products in focus · 04/11/2025

Peppermint (Mentha piperita) is a common herb, also known as a hybrid mint. Its main components are oxygenated monoterpenes: alcohols, esters and ketones. Peppermint oleoresin microencapsulated powder is a white to off-white coloured powder produced from the seeds of the plant. In order to protect and maintain the stability of peppermint oil, microencapsulation is carried out through process  optimization using the coacervation technique. This technique helps limit the loss and degradation of flavours and aromas during processing and storage. It offers versatile applications across multiple industries — from food and beverages to pharmaceuticals, cosmetics, and textiles.

Titanium dioxide loses EU carcinogen label after court ruling
News · 01/11/2025

Products containing titanium dioxide in the EU are no longer required to carry warnings about cancer risk, after the European Chemicals Agency (Echa) revoked its classification as a suspected carcinogen. The move follows a June 2025 decision by the Court of Justice of the European Union and means that safety data sheets, labelling and packaging requirements for titanium dioxide have been relaxed across industries including paints, pharmaceuticals, cosmetics and food.

In focus: 5-Methyl-3-vinyl-2-oxazolidinone
Products in focus · 14/10/2025

5-Methyl-3-vinyl-2-oxazolidinone (V-MOX) is a highly reactive monomer valued for its low viscosity, mild odor, and excellent reactivity. It is widely used as a reactive diluent in UV-curable inks and coatings, where it enhances adhesion, produces brighter colors, and improves safety compared to conventional diluents. In addition, V-MOX serves as a key building block in the synthesis of kinetic hydrate inhibitor (KHI) polymers, which are applied in oil and gas production to prevent hydrate blockages in pipelines.